Sweegen Expands Sugar Reduction Portfolio With High-Intensity Sweetener Brazzein

Rancho Santa Margarita, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) — Sweegen is expanding its extensive sweetener portfolio in early 2022 with the zero-calorie, high-intensity sweetener brazzein.  The product was developed in collaboration with long-term innovation partner Conagen, which has scaled it to commercial production. Brazzein is a small, heat-stable protein, 500 to 2,000 times sweeter than regular sugar, making it very attractive to food and beverage manufacturers seeking excellent value in a sweetener.

As a sweetener, brazzein promises little to no bitter aftertaste and helps to reduce sweet linger, reducing taste modulation challenges in the natural sweetener space. Brazzein is stable in a wide range of pH and retains its qualities after pasteurization.  It is also readily soluble, making it ideal for sugar reduction across a spectrum of food and beverage applications.

“Introducing a high-purity brazzein to Sweegen’s portfolio of natural sweeteners is one more creative solution for helping brands make low-calorie better-for-you products,” said Sweegen’s SVP, Head of Global Innovation, Shari Mahon. “Brands can look forward to exploring the synergistic benefits of combining brazzein and stevia for reducing sugar in food and beverages in a cost-effective way.”

As a sweet protein, brazzein has great promise to fit into consumer diets, such as Keto, diabetes, or low-to-no carbohydrate lifestyles. Health-conscious consumers are also turning away from artificial sweeteners and accepting nature-based sweeteners, such as stevia and allulose.

Brazzein’s extraordinary qualities stand out among high-intensity sweeteners, but the quest to scale and commercialize it has proven difficult until now. Found sparingly in nature, brazzein derives from the West African climbing plant’s fruit, oubli. To scale brazzein sustainably, Conagen produces it by a proprietary precision fermentation process, a technology producing clean, nature-based ingredients.

“Brazzein is the first product generated from our new peptide platform, which fits well into our existing world-scale, precision fermentation infrastructure,” said Conagen’s Vice President of Innovation, Casey Lippmeier, Ph.D. “Peptides and small proteins like brazzein can be very difficult to make economically.  However, now that we have successfully scaled this peptide, we expect more sustainable, novel peptide ingredients will rapidly follow.”

About Sweegen

Sweegen provides sweet taste solutions for food and beverage manufacturers around the world.

We are on a mission to reduce the sugar and artificial sweeteners in our global diet.  Partnering with customers, we create delicious zero-sugar products that consumers love.  With the best next-generation stevia sweeteners in our portfolio, such as Signature Bestevia® Rebs B, D, E, I, M, and N, along with our deep knowledge of flavor modulators and texturants, Sweegen delivers market-leading solutions that customers want, and consumers prefer. Be well. Choose well.

For more information, please contact info@sweegen.com and visit Sweegen’s website, www.sweegen.com.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains forward-looking statements, including, among other statements, statements regarding the future prospects for Reb M stevia leaf sweetener. These statements are based on current expectations but are subject to certain risks and uncertainties, many of which are difficult to predict and are beyond the control of Sweegen, Inc.

Relevant risks and uncertainties include those referenced in the historic filings of Sweegen, Inc. with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. Sweegen, Inc. assumes no obligation to update any forward-looking statements due to new information or future events or developments.

Attachments

Ana Arakelian
Sweegen
+1.949.709.0583
ana.arakelian@sweegen.com

New Research in Kosovo Highlights Connection Between Children’s Poor Vision and Learning and Development

Study underscores link between uncorrected poor vision and children’s potential

DALLAS, Oct. 4, 2021 /PRNewswire/ — A new study, a collaboration of  the Vision Impact Institute, EdGuard Institute, and ESSILOR’s Vision for Life™ social impact fund, offers new insight into the correlation between uncorrected poor vision and children’s functional, learning, and behavioral capacities.

Vision Impact Institute logo

The study, the first of its kind conducted in Kosovo’s schools, suggests that one in three children reported difficulties seeing the board in their classroom.  Findings also show that children with poor vision have a higher risk of developing incapacitating symptoms than children with good vision. These children:

  • Often report headaches and eye disorders (tired, itching, burning eyes), and modify their physical behavior when learning: squinting, getting closer to the book, resting on their wrist, or sitting in the first desk.
  • Have their learning capacity (reading, writing, doing homework) affected more often than children with good vision, and encounter more difficulties playing sports.
  • Feel uncomfortable when playing with others, and frustrated when poor eyesight hinders completion of homework.

“This research is an important collaborative effort, because it not only addresses the issues that children with poor vision experience when learning, but also addresses the psychosocial impact that affects how children learn to interact with their peers and their environment,” says Eva Lazuka-Nicoulaud, Director, Europe and Africa.

“The baseline findings show the need to develop a sustainable roadmap and introduce policies to ensure every child has access to universal eye care services,” says Kristan Gross, Global Executive Director. “All stakeholders, parents, teachers, and eye care professionals have a role to play in creating a foundation for a healthy and productive future for children.”

About the Vision Impact Institute
The Vision Impact Institute’s mission is to raise awareness of the importance of vision correction and protection to make good vision a global priority. Its Advisory Board is comprised of four independent international experts: Pr. Clare Gilbert (United Kingdom), Mr. Allyala Nandakumar (United States),   Dr. Serge Resnikoff (Switzerland), and Dr. Wang Wei (China).

The Vision Impact Institute is a registered 501(c)(3) non-profit organization, which receives support from the Vision for Life Fund from Essilor, the world leader in ophthalmic optics. The Vision Impact Institute hosts a unique database of research  and advocacy  tools at  visionimpactinstitute.org .

Contact:

Kristan Gross
Global Executive Director
kristan.gross@visionimpactinstitute.org

Logo – https://mma.prnewswire.com/media/832635/Vision_Impact_Institute_Logo.jpg

‘Captain Kirk’ Heading to Space

Actor William Shatner, best known for his portrayal of space explorer Captain James T. Kirk in the “Star Trek” television series, announced he will travel to space later this month.

Shatner, 90, will blast off October 12 aboard a Blue Origin rocket. Blue Origin is the space travel company of Amazon founder Jeff Bezos.

If successful, Shatner would be the oldest person ever to travel to space. He will be joined by three other passengers on Blue Origin’s second space venture.

Bezos was among the first Blue Origin passengers in July.

The flight is expected to last about 10 minutes and reach an altitude of 106 kilometers.

“I’ve heard about space for a long time now. I’m taking the opportunity to see it for myself. What a miracle,” Shatner said in a statement.

In a tweet, the actor wrote, “So now I can say something. Yes, it’s true; I’m going to be a ‘rocket man!’ a referral to his spoken-word cover version of singer-songwriter Elton John’s famous song.

Source: Voice of America

ENI INVESTS IN BIOFUELS IN ANGOLA

Luanda – The Italian oil company ENI is proposing to invest, in Angola, between US $100,000 and 150 million in the construction of 35 agricultural centres for the production of cereals for biofuels.

The manager of the Italian oil company, Claudio Descalzi, announced this Monday to the press, at the end of a meeting with the President of the Republic, João Lourenço, that in the next five years, ENI will preferably invest in land that is not conflicting with the food needs of Angolans.

He revealed that the cereals will feed Italian bio-refineries, which have an annual production capacity of 1.1 billion tons of biofuel.

Claudio Descalzi believes that in the next three years, the capacity of these refineries will be added for another million tons of fuel.

He informed that, in those agricultural lands, Castor bean will be produced, a grain resistant to the weather, and suitable for this type of fuel.

The leader of the Italian oil company expressed his intention to build a bio-refinery in Angola, without advancing on the deadlines.

Bio-fuels are renewable energy sources, produced from organic matter of animal or vegetable origin (eucalyptus, sugarcane, castor beans).

Before the meeting with the Head of State, the Italian oil company ENI, the National Oil and Gas Agency (ANPG) and SONANGOL signed a cooperation agreement for the production of biofuels, in order to boost the energy transition sector.

The agreement, signed within the scope of the National Biofuels Strategy, establishes, among other targets, goals and principles for the production of biofuels in Angola, in line with the commitments assumed internationally, through the Kyoto Protocol.

Adopted in 1997 in Japan, the Kyoto Protocol is a global agreement resulting from the United Nations Framework Convention on Climate Change.

Source: Angola Press News Agency

Biden Lifts Abortion Referral Ban on Family Planning Clinics

The Biden administration on Monday reversed a ban on abortion referrals by family planning clinics, lifting a Trump-era restriction as political and legal battles over abortion grow sharper from Texas to the U.S. Supreme Court.

The Department of Health and Human Services said its new regulation will restore the federal family planning program to the way it ran under the Obama administration, when clinics were able to refer women seeking abortions to a provider.

Groups representing the clinics said they hope the Biden administration action will lead hundreds of service providers that left in protest over Trump’s policies to return, helping to stabilize a longstanding program that has been shaken by the coronavirus pandemic on top of ideological battles.

Known as Title X, the taxpayer-funded program makes available more than $250 million a year to clinics to provide birth control and basic health care services mainly to low-income women. Under former President Donald Trump, clinics were barred from referring patients for abortions, prompting a mass exit by service providers affiliated with Planned Parenthood, as well as several states and other independent organizations.

Women’s groups labeled the Trump policy a “gag rule,” and medical organizations called it a violation of the clinician-patient relationship. But religious and social conservatives praised the policy for imposing a strict separation between family planning services and abortion. Under federal law, clinics could not use federal money to pay for abortions.

In 2018, the family planning clinics served about 3.9 million clients, but HHS estimates that number fell by nearly 40% after the Trump policy. The upheaval may have led to more than 180,000 unintended pregnancies, the agency said.

Biden campaigned on a promise to overturn the restrictions on family planning clinics, but abortion was not a central issue in the 2020 presidential race. It may become one in the 2022 midterm elections to determine who controls Congress.

U.S. Supreme Court

Restrictive state laws in Texas, Mississippi and elsewhere have prompted a mobilization by abortion rights supporters, who fear a conservative-leaning Supreme Court will overturn the 1973 Roe v. Wade decision that legalized abortion nationally. Hundreds of abortion-themed protests were held around the country Saturday, including one that brought thousands of abortion rights supporters to the steps of the court.

The Supreme Court has allowed the Texas law to take effect but has not ruled on the substantive legal questions behind that statute, which bans most abortions in the state. The justices will hear arguments December 1 on the Mississippi law, which bans most abortions after 15 weeks of pregnancy.

Source: Voice of America

COVID-19: ANGOLA FORESEES TO VACCINE 15 MILLION PEOPLE

Luanda – Angola plans to vaccinate around 15 million citizens over the age of 18 against Covid-19, said this Monday, in Luanda, the President of the Republic, João Lourenço.

The Angolan statesman spoke to the press after visiting the headquarters of the Multi-sector Commission for the Prevention and Fight against Covid-19.

For the President of the Republic, the solution to the problem of Covid-19 calls for, along with other secondary measures, massive campaigns of vaccination, which have to include the participation of resident foreign citizens.

According to President João Lourenço, Angola is to receive, by the end of this year, other 7.7 million doses of vaccine from “Sinopharm”.

The president believes that the degree of adherence to vaccination posts is improving day after day, and that the Executive can guarantee that there will be no shortage of vaccines.

The President also stressed that the country is close to the intended goal and assured that more vaccination posts will be opened throughout the country, in order to match the level of attendance, concentrating most of them in Luanda, which houses close to a third of the country’s population.

Asked about the position of citizens who claim that there is no constitutional obligation for vaccination, João Lourenço recalled that the vaccine only brings benefits and does not harm anyone.

Health authorities announced, this Monday, the registration of 428 new cases, 7 deaths and the recovery of 67 patients.

Source: Angola Press News Agency